These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 7721232)

  • 21. Cardiac and vascular effects of NZ-105, a novel dihydropyridine derivative, in vitro.
    Masuda Y; Iwama T; Yamashita T; Sakai T; Hibi M; Tanaka S; Shigenobu K; Kasuya Y
    Arch Int Pharmacodyn Ther; 1991; 314():57-73. PubMed ID: 1668604
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of [3H]isradipine binding to L-type calcium channels by the optical isomers of isoflurane. Lack of stereospecificity.
    Moody EJ; Harris B; Hoehner P; Skolnick P
    Anesthesiology; 1994 Jul; 81(1):124-8. PubMed ID: 8042780
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Selective modulation by membrane potential of desmethoxyverapamil binding to calcium channels in rat portal vein.
    Rakotoarisoa L; Sayet I; Mironneau C; Mironneau J
    J Pharmacol Exp Ther; 1990 Dec; 255(3):942-7. PubMed ID: 2175807
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacological in vitro studies of the new 1,4-dihydropyridine calcium antagonist lercanidipine.
    Guarneri L; Angelico P; Ibba M; Poggesi E; Taddei C; Leonardi A; Testa R
    Arzneimittelforschung; 1996 Jan; 46(1):15-24. PubMed ID: 8821512
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of myocardial Ca2+ channels by three dihydropyridines with different structural features: potential-dependent blockade by Ro 18-3981.
    Holck M; Osterrieder W
    Br J Pharmacol; 1987 May; 91(1):61-7. PubMed ID: 2439160
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Neuropharmacological characterization of voltage-sensitive calcium channels: possible existence of neomycin-sensitive, omega-conotoxin GVIA- and dihydropyridines-resistant calcium channels in the rat brain.
    Yamada K; Teraoka T; Morita S; Hasegawa T; Nabeshima T
    Jpn J Pharmacol; 1993 Dec; 63(4):423-32. PubMed ID: 8121077
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Differential labelling of putative skeletal muscle calcium channels by [3H]-nifedipine, [3H]-nitrendipine, [3H]-nimodipine and [3H]-PN 200 110.
    Ferry DR; Goll A; Glossmann H
    Naunyn Schmiedebergs Arch Pharmacol; 1983 Jul; 323(3):276-7. PubMed ID: 6312337
    [TBL] [Abstract][Full Text] [Related]  

  • 28. MPC-1304, another type of dihydropyridine, possessing highly potent vasodilating action.
    Miyoshi K; Kanda A; Miyake H; Ichihara K; Kamei H; Nagasaka M
    Eur J Pharmacol; 1993 Jul; 238(2-3):139-48. PubMed ID: 7691619
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comparative study of elgodipine and nisoldipine on the contractile responses of various isolated blood vessels.
    Chulia T; Gonzalez P; Del Rio M; Tejerina T
    Eur J Pharmacol; 1995 Oct; 285(2):115-22. PubMed ID: 8566128
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Binding of the new calcium entry blocker nilvadipine to rat aortic and guinea pig left ventricular membranes.
    Matsuo M; Koibuchi Y; Tomoi M; Ono T; Shibayama F; Ohtsuka M
    Arzneimittelforschung; 1989 May; 39(5):576-9. PubMed ID: 2757673
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A new site for the activation of cardiac calcium channels defined by the nondihydropyridine FPL 64176.
    Rampe D; Lacerda AE
    J Pharmacol Exp Ther; 1991 Dec; 259(3):982-7. PubMed ID: 1662279
    [TBL] [Abstract][Full Text] [Related]  

  • 32. (+)-[3H]isradipine and [3H]glyburide bindings to heart and lung membranes from rats with monocrotaline-induced pulmonary hypertension.
    Nakayama K; Fukuta Y; Kiyoshi A; Iwatsuki Y; Ishii K; Ishikawa T; Iida M; Iwata H; Enomoto M
    Jpn J Pharmacol; 1999 Oct; 81(2):176-84. PubMed ID: 10591475
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative potencies of calcium channel antagonists and antischizophrenic drugs on central and peripheral calcium channel binding sites.
    Quirion R; Lafaille F; Nair NP
    J Pharm Pharmacol; 1985 Jun; 37(6):437-40. PubMed ID: 2410588
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Vascular selectivity of seven prototype calcium antagonists: a study at the single cell level.
    Pérez-Vizcaíno F; Tamargo J; Hof RP; Rüegg UT
    J Cardiovasc Pharmacol; 1993 Nov; 22(5):768-75. PubMed ID: 7506331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. AE0047-mediated calcium channel blocking in vascular smooth muscles.
    Yamanaga K; Shinyama H; Akira T; Iwamoto M; Uchida T; Nakamura N; Kagitani Y
    Gen Pharmacol; 1997 Sep; 29(3):337-43. PubMed ID: 9378237
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vivo measurement of 1,4-dihydropyridine receptors in mesenteric arteries of spontaneously hypertensive rats and effect of nifedipine and cilnidipine.
    Nakajima M; Yamada S; Uchida S; Kimura R
    Biol Pharm Bull; 2002 Jan; 25(1):24-8. PubMed ID: 11824551
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Analysis of the properties of binding of calcium-channel activators and inhibitors to dihydropyridine receptors in chick heart membranes.
    Maan AC; Hosey MM
    Circ Res; 1987 Sep; 61(3):379-88. PubMed ID: 2441891
    [TBL] [Abstract][Full Text] [Related]  

  • 38. High and low affinity states of the dihydropyridine and phenylalkylamine receptors on the cardiac calcium channel and their interconversion by divalent cations.
    Ptasienski J; McMahon KK; Hosey MM
    Biochem Biophys Res Commun; 1985 Jun; 129(3):910-7. PubMed ID: 2409972
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cardiovascular profile of oxodipine, a novel dihydropyridine calcium channel blocker, in anesthetized open-chest dogs: a comparison with nitrendipine.
    Alloui A; Talmant JM; Duchêne-Marullaz P
    Arch Int Pharmacodyn Ther; 1991; 313():63-75. PubMed ID: 1816765
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Cardiac inotropic vs. chronotropic selectivity of isradipine, nifedipine and clevidipine, a new ultrashort-acting dihydropyridine.
    Segawa D; Sjöquist PO; Nordlander M; Wang QD; Gonon A; Rydén L
    Eur J Pharmacol; 1999 Sep; 380(2-3):123-8. PubMed ID: 10513571
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.